Last reviewed · How we verify
Inoculation in vastus lateralis muscle
This is an intramuscular injection administered to the vastus lateralis muscle, likely a vaccine formulation developed by Beijing CDC.
At a glance
| Generic name | Inoculation in vastus lateralis muscle |
|---|---|
| Sponsor | Beijing Center for Disease Control and Prevention |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
The entry describes an inoculation procedure (injection into the vastus lateralis muscle) rather than a specific drug with a defined molecular mechanism. Without identification of the vaccine antigen or target pathogen, the precise immunological mechanism cannot be determined. Beijing Center for Disease Control and Prevention develops vaccines for infectious disease prevention.
Approved indications
Common side effects
Key clinical trials
- The Effect of Simultaneous Versus Sequential Intramuscular Vaccine Injections on Pain Levels in Infants (NA)
- Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years (PHASE1)
- Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors (PHASE1)
- The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination (NA)
- The Effect of Facilitated-tucking and ShotBlocker on Pain Caused by Vaccination in Healthy Infants (NA)
- Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II (PHASE2)
- Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life (PHASE4)
- Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: